HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 6, 5113-5120, February 11, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/6/5113    most recent M413403200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, J. Articles by Spiegel, A. M. Search for Related Content PubMed PubMed Citation Articles by Hu, J. Articles by Spiegel, A. M. Social Bookmarking                      What's this?

A Region in the Seven-transmembrane Domain of the Human Ca²⁺ Receptor Critical for Response to Ca^2+*

Jianxin Hu, Stuart J. McLarnon, Stefano Mora¶, Jiankang Jiang||, Craig Thomas||, Kenneth A. Jacobson||, and Allen M. Spiegel

From the Molecular Pathophysiology Section, NIDCD, National Institutes of Health, Bethesda, Maryland 20892, ^¶Laboratory of Pediatric Endocrinology and Department of Pediatrics, Scientific Institute H San Raffaele, Milan 20132, Italy, and ^||Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892

Of 12 naturally occurring, activating mutations in the seven-transmembrane (7TM) domain of the human Ca²⁺ receptor (CaR) identified previously in subjects with autosomal dominant hypocalcemia (ADH), five appear at the junction of TM helices 6 and 7 between residue Ile⁸¹⁹ and Glu⁸³⁷. After identifying a sixth activating mutation in this region, V836L, in an ADH patient, we studied the remaining residues in this region to determine whether they are potential sites for activating mutations. Alanine-scanning mutagenesis revealed five additional residues in this region that when substituted by alanine led to CaR activation. We also found that, whereas E837A did not activate the receptor, E837D and E837K mutations did. Thus, region Ile⁸¹⁹–Glu⁸³⁷ of the 7TM domain represents a "hot spot" for naturally occurring, activating mutations of the receptor, and most of the residues in this region apparently maintain the 7TM domain in its inactive configuration. Unique among the residues in this region, Pro⁸²³, which is highly conserved in family 3 of the G protein-coupled receptors, when mutated to either alanine or glycine, despite good expression severely impaired CaR activation by Ca²⁺. Both the P823A mutation and NPS 2143, a negative allosteric modulator that acts on the 7TM through a critical interaction with Glu⁸³⁷, blocked activation of the CaR by various ADH mutations. These results suggest that the 7TM domain region Ile⁸¹⁹–Glu⁸³⁷ plays a key role in CaR activation by Ca²⁺. The implications of our finding that NPS 2143 corrects the molecular defect of ADH mutations for treatment of this disease are also discussed.

Received for publication, November 29, 2004 , and in revised form, December 9, 2004.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Bldg. 10, Rm. 8C-101, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892. Tel.: 301-496-9212; Fax: 301-402-0374; E-mail: jianxinh{at}intra.niddk.nih.gov.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Yanagawa, T. Yamashita, and Y. Shichida Activation Switch in the Transmembrane Domain of Metabotropic Glutamate Receptor Mol. Pharmacol., July 1, 2009; 76(1): 201 - 207. [Abstract] [Full Text] [PDF]

				M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells Cardiovasc Res, February 1, 2009; 81(2): 260 - 268. [Abstract] [Full Text] [PDF]

				D. Riccardi and D. Martin The Role of the Calcium-Sensing Receptor in the Pathophysiology of Secondary Hyperparathyroidism NDT Plus, January 1, 2008; 1(suppl_1): i7 - i11. [Abstract] [Full Text] [PDF]

				S. Smajilovic and J. Tfelt-Hansen Calcium acts as a first messenger through the calcium-sensing receptor in the cardiovascular system Cardiovasc Res, August 1, 2007; 75(3): 457 - 467. [Abstract] [Full Text] [PDF]

				Y. Huang and G. E. Breitwieser Rescue of Calcium-sensing Receptor Mutants by Allosteric Modulators Reveals a Conformational Checkpoint in Receptor Biogenesis J. Biol. Chem., March 30, 2007; 282(13): 9517 - 9525. [Abstract] [Full Text] [PDF]

				J. Hu, J. Jiang, S. Costanzi, C. Thomas, W. Yang, J. H. M. Feyen, K. A. Jacobson, and A. M. Spiegel A Missense Mutation in the Seven-transmembrane Domain of the Human Ca2+ Receptor Converts a Negative Allosteric Modulator into a Positive Allosteric Modulator J. Biol. Chem., July 28, 2006; 281(30): 21558 - 21565. [Abstract] [Full Text] [PDF]

				J. T. Brosnan and M. E. Brosnan Branched-Chain Amino Acids: Enzyme and Substrate Regulation J. Nutr., January 1, 2006; 136(1): 207S - 211S. [Abstract] [Full Text] [PDF]

				M. Pi, P. Faber, G. Ekema, P. D. Jackson, A. Ting, N. Wang, M. Fontilla-Poole, R. W. Mays, K. R. Brunden, J. J. Harrington, et al. Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor J. Biol. Chem., December 2, 2005; 280(48): 40201 - 40209. [Abstract] [Full Text] [PDF]

				C. Silve, C. Petrel, C. Leroy, H. Bruel, E. Mallet, D. Rognan, and M. Ruat Delineating a Ca2+ Binding Pocket within the Venus Flytrap Module of the Human Calcium-sensing Receptor J. Biol. Chem., November 11, 2005; 280(45): 37917 - 37923. [Abstract] [Full Text] [PDF]

				E. Seeman and G. J. Strewler Clinical and Basic Research Papers - January 2005 Selections IBMS BoneKEy, February 1, 2005; 2(2): 1 - 6. [Full Text] [PDF]